Bioreactors Market Analysis, Size, Industry Trends and Forecast to 2024 | Hexa Research

Your Catalyst To a Lucrative Business
Bioreactors Market Analysis, Size, Share, Growth, Industry Trends and
Forecast to 2024 | Hexa Research
" The worldwide bioreactors market is projected over
USD 550 million by 2024, growing at a CAGR above
18% during the forecast period (2016-2024).
The worldwide bioreactors Market is anticipated to generate revenues over USD 550 million by 2024. It will
grow at a CAGR above 18% in the forecast period (2016-2024). The industry is driven by the demand for
biologics and adoption of single-use bioreactors (SUBs) & hybrid bioreactors. Rising popularity of SUBs in
pharmaceutical manufacturing companies is yet another key driver.
SUBs or disposable bioreactors contain disposable bags instead of cultural vessels. They face high demand
from the medical sector. These reactors are adopted by pharmaceutical companies to manufacture drugs
without any negotiations on their quality. These systems differ in view of flexibility and cultural medium.
Commercial bioreactors include CellMarket Regular from Cellexus and HyClone SUB from Thermo Fisher
Low functional costs of SUBs and low maintenance required for them can propel market demand from 2016
to 2024. Moreover, convenience associated with marine-microbe culturing coupled with low energy
consumption by SUBs could favor these reactors. But low volume capacities of SUBs can hamper the
Browse Details of [email protected]
Follow Us:
Your Catalyst To a Lucrative Business
The worldwide Bioreactors Market is fragmented on the basis of products, cells, molecules, technologies,
end-users, and regions. Products include monoclonal antibodies and recombinant proteins. Monoclonal
antibodies are projected to reign owing to their efficiency in medical treatments. Yeast, bacteria, and
mammalian cells are the various cells. Mammalian cells should be the most rapidly growing segment. This will
be attributed to their high bio-molecular effectiveness.
Recombinant proteins, monoclonal antibodies (MAbs), gene therapy, stem cells, and vaccines are classified
under molecules. MAbs are used by biologics industry to manufacture vaccines. This may augments the
demand for bioreactors in the next eight years. Low investment costs of SUBs to make MAbs on a small scale
can add to overall market demand.
Single use bubble column bioreactor, stirred SUBs, and wave-induced motion SUBs constitute the
technologies. Wave-induced motion SUBs are likely to notice the highest growth rate till 2024. Surging
growth can be attributed to their high flexibility and short lead times.
End-users in the Bioreactors Market comprise R&D departments and biopharmaceutical manufacturers. The
former are sub-divided into biopharmaceutical companies, contract research organizations (CROs), and
research institutes.
Regions are Asia Pacific, North America, Europe, and RoW (Rest of the World). North A merica & Europe
would garner major shares by 2024. This will be ascribed to their key biopharmaceutical firms.
Europe is predicted to capture large shares due to biologic drug patents reaching expiry. Also, regional
assistance for biologic manufacturers to produce drugs with high effectiveness should benefit the region.
Asia Pacific is likely to display significant expansion because of investment opportunities for its major biologic
manufacturers. Key firms opening their manufacturing units in Latin America will benefit the region.
Key companies in the global Bioreactors Market are GE Healthcare, Thermo Fisher Scientific Inc., Merck
KGaA, and Sartorius Stedim Biotech S.A. They are expected to further their product portfolio and offer system
This could make consumer segments well-acquainted with various blends of bioprocessing components. It
can also help them with buying decisions. Product endorsements via commercial manufacturing to obtain the
finest application solutions may augur well for the market.
Browse Related Category Market Reports @
Follow Us:
Your Catalyst To a Lucrative Business
Table of Content of Bioreactors Market
Table of Contents
1. Methodology & Scope
1.1 Research Methodology
1.1.1 Initial Data Exploration
1.1.2 Statistical Modeling and Forecast
1.1.3 Industry Insights and Validation
1.2 Research Scope & Assumptions
1.3 List of Data Sources
2. Executive Summary
2.1 Industry Summary of Bioreactors Market
3. Industry Outlook
3.1 Bioreactors Market Segmentation
3.2 Bioreactors Market Size and Growth Prospects
3.3 Bioreactors Market Dynamics
3.4 Key Opportunities Prioritized
3.5 Industry Analysis - Porter's
3.6 Market Share Analysis
3.7 Market PESTEL Analysis, 2016
4. Application Framework
4.1 Bioreactors Market share by application, 2016 & 2024
5. Regional Outlook
5.1 North America
5.2 Europe
5.3 Asia Pacific
5.4 Latin America
5.5 MEA (Middle East and Africa)
5.6 RoW (Rest of the World)
Follow Us:
Your Catalyst To a Lucrative Business
6. Competitive Landscape
6.1 GE Healthcare
6.1.1 Company Overview
6.1.2 Revenue Analysis
6.1.3 Product Benchmarking
6.1.4 Strategic Initiatives
6.2 Thermo Fisher Scientific Inc.
6.2.1 Company Overview
6.2.2 Revenue Analysis
6.2.3 Product Benchmarking
6.2.4 Strategic Initiatives
6.3 Merck KGaA
6.3.1 Company Overview
6.3.2 Revenue Analysis
6.3.3 Product Benchmarking
6.3.4 Strategic Initiatives
6.4 Sartorius Stedim Biotech S.A.
6.4.1 Company Overview
6.4.2 Revenue Analysis
6.4.3 Product Benchmarking
6.4.4 Strategic Initiatives
Follow Us:
Your Catalyst To a Lucrative Business
About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom research
and consulting services to a host of key industries across the globe. We offer comprehensive business
intelligence in the form of industry reports which help our clients obtain clarity about their business
environment and enable them to undertake strategic growth initiatives.
Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: [email protected]
Website -
Visit Our Blog:
Follow Us:

The worldwide bioreactors market is projected over USD 550 million by 2024, growing at a CAGR above 18% during the forecast period (2016-2024).